Article, originally published in JAMA Neurology
Researchers observed no difference in functional neurodevelopment or epilepsy among children aged 24 months regardless of whether anti-seizure medication was discontinued or maintained in infants at discharge once seizures ceased.
Results of the comparative effectiveness study were published in JAMA Neurology.
“These results support discontinuing anti-seizure medications (ASMs) for most neonates with acute symptomatic seizures prior to discharge from the hospital, an approach that may represent an evidence-based change in practice for many clinicians,” Hannah C. Glass, MDCM, MAS, a pediatric neurologist, founding codirector of the neurointensive care nursery and director of neonatal critical care services at the University of California, San Francisco Benioff Children’s Hospital, and colleagues wrote.